PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study.

J Clin Pathol · 2024 · PMC11503171 · PMID 37344170

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

of borderline significancep=0.064so close (0.05 < p ≤ 0.1)

At baseline, ph-mTOR showed a negative association of borderline significance with RFS (HR 2.39, 95% CI 0.94 to 6.02, p=0.064) ( figure 3A ).

also in 421 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.